Shorter illness duration:
The duration of respiratory infections was on average 50 percent shorter with ColdZyme.
The evidence behind ColdZyme®
The latest independent study shows that ColdZyme shortens illness duration, alleviates symptoms, and reduces viral loads in upper respiratory tract infections. ColdZyme addresses the underlying cause of upper respiratory infections by physically inhibiting the virus's spread and protecting the cells in the airways. The results reinforce ColdZyme’s position as an effective support for fighting the cause of colds, both for athletes and the general public.
Key results from the study
-
-
Reduced symptoms:
Study participants who used ColdZyme experienced significantly fewer cold symptoms.
-
Reduced viral load:
Median amount of virus was reduced by 94 percent.
The evidence behind ColdZyme®
The latest independent study shows that ColdZyme shortens illness duration, alleviates symptoms, and reduces viral loads in upper respiratory tract infections. ColdZyme addresses the underlying cause of upper respiratory infections by physically inhibiting the virus's spread and protecting the cells in the airways. The results reinforce ColdZyme’s position as an effective support for fighting the cause of colds, both for athletes and the general public.
Key results from the study
-
Shorter illness duration:
The duration of respiratory infections was on average 50 percent shorter with ColdZyme.
-
Reduced symptoms:
Study participants who used ColdZyme experienced significantly fewer cold symptoms.
-
Reduced viral load:
Median amount of virus was reduced by 94 percent.